Elsevier × JAMA Network
Elsevier and the JAMA Network announced a strategic content agreement to integrate the full-text content and visuals from 13 JAMA Network journals into Elsevier's ClinicalKey AI platform. The deal allows the AI tool, which is aimed at clinicians, to ground its answers in the peer-reviewed, evidence-based content from the prestigious medical journals. Financial terms of the agreement were not disclosed.
The asset
A license for the full-text content and visuals from the 13 journals in the JAMA Network Family of Journals to be used to inform answers within Elsevier's ClinicalKey AI product.
- 13 journals
The record
- Seller status
- Going concern
- Sector
- Medical journal publishing
- Modalities
- text, images
- Jurisdiction
- US
- Personal data
- The buyer's platform, ClinicalKey AI, is described as supporting HIPAA-compliant use in North America with privacy and security controls to protect patient health information.
What it means if you hold data
This deal highlights the increasing value of authoritative, brand-name content for training and grounding vertical-specific AI tools, particularly in high-stakes fields like medicine where trust and evidence are paramount. It demonstrates a model where AI developers license high-quality data to enhance product reliability and user confidence, rather than relying on publicly scraped data.